Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain 7Neoplasms 3Pain, Postoperative 2Malignant Female Reproductive System Neoplasm 2Hematologic Neoplasms 2Emergencies 2Agnosia 2Uterine Cervical Neoplasms 1Tumor Surgery 1Sarcoma 1Rectal Neoplasms 1Pulmonary Nodule 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Pain, Intractable 1Ovarian Neoplasms 1Neuralgia 1Neoplasm Metastasis 1Mucositis 1Lymphoma, Follicular 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Intraoperative Complications 1Ileus 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Duodenal Neoplasms 1Diverticulosis, Colonic 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Hydromorphone × Clear all
NCT02461056 2015-06-03

Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain

Samsung Medical Center

Phase NA Completed
90 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡